Taenia Solium Taeniosis/Cysticercosis and the Co-Distribution with Schistosomiasis in Africa Uffe Christian Braae1*, Christopher F

Taenia Solium Taeniosis/Cysticercosis and the Co-Distribution with Schistosomiasis in Africa Uffe Christian Braae1*, Christopher F

Braae et al. Parasites & Vectors (2015) 8:323 DOI 10.1186/s13071-015-0938-7 RESEARCH Open Access Taenia solium taeniosis/cysticercosis and the co-distribution with schistosomiasis in Africa Uffe Christian Braae1*, Christopher F. L. Saarnak1, Samson Mukaratirwa2, Brecht Devleesschauwer3,4, Pascal Magnussen1,5 and Maria Vang Johansen1 Abstract Background: This study aimed to map the distribution of Taenia solium taeniosis/cysticercosis and the co-distribution with schistosomiasis in Africa. These two major neglected tropical diseases are presumed to be widely distributed in Africa, but currently the level of co-distribution is unclear. Methods: A literature search on T. solium taeniosis/cysticercosis was performed to compile all known studies on the presence of T. solium and apparent prevalence of taeniosis and porcine cysticercosis in Africa. Studies were geo-referenced using an online gazetteer. A Bayesian framework was used to combine the epidemiological data on the apparent prevalence with external information on test characteristics to estimate informed district-level prevalence of taeniosis and porcine cysticercosis. Districts with T. solium taeniosis/cysticercosis presence were cross-referenced with the Global Neglected Tropical Diseases Database for schistosomiasis presence. Results: The search strategies identified 141 reports of T. solium in Africa from 1985 to 2014 from a total of 476 districts in 29 countries, 20 with porcine cysticercosis, 22 with human cysticercosis, and 16 with taeniosis, in addition to 2 countries identified from OIE reports. All 31 countries were considered, on national scale, to have co-distribution with schistosomiasis. Presence of both parasites was confirmed in 124 districts in 17 countries. The informed prevalence of taeniosis and porcine cysticercosis were estimated for 14 and 41 districts in 10 and 13 countries, respectively. Conclusions: With the paucity of data, T. solium infection is grossly under-reported and expected to be more widespread than this study suggests. In areas where co-distribution occurs there is a need for increased emphasis on evaluation of integrated intervention approaches for these two helminth infections and allocation of resources for evaluating the extent of adverse effects caused by mass drug administration. Keywords: African pig population, Co-distribution, Cysticercosis, Mapping, Prevalence, Schistosomiasis, Taenia solium Background been performed using several diagnostic tests with varying The major neglected tropical diseases, Taenia solium sensitivity and specificity [3–5]. Therefore, estimating in- taeniosis/cysticercosis and schistosomiasis caused by formed prevalence is important to determine the actual Schistosoma mansoni or S. haematobium are presumed to disease burden. Informed prevalence is an estimation of be widely distributed in Africa. Taenia solium taeniosis/ the true prevalence based on the apparent prevalence cysticercosis has been reported as an emerging disease in while factoring in the imperfections in sensitivity and spe- different regions of Africa [1, 2], but currently the exact cificity of the diagnostic tests used. The distribution of distribution remains unclear. Reported prevalences of schistosomiasis in Africa has been more extensively inves- T. solium taeniosis and cysticercosis in African countries tigated than T. solium taeniosis/cysticercosis and this has are not extensive and are further complicated by the lack allowed for country level prevalence and risk estimation of of ‘gold standard’ tests for diagnosis. Diagnosis has so far schistosomiasis for all African countries [6]. The World Health Organization (WHO) is aiming for * Correspondence: [email protected] elimination of schistosomiasis by 2020 and the road map 1Department of Veterinary Disease Biology, Section for Parasitology and Aquatic Diseases, Faculty of Health and Medical Sciences, University of for elimination of T. solium taeniosis/cysticercosis is under Copenhagen, DK-1870 Frederiksberg, Denmark consideration by the WHO [7]. The WHO strategy for Full list of author information is available at the end of the article © 2015 Braae et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Braae et al. Parasites & Vectors (2015) 8:323 Page 2 of 14 schistosomiasis elimination is primarily mass drug admin- Methods istration (MDA) of preventive chemotherapy as the main Literature search intervention tool. The WHO advocates that MDA against The following data were included in this study 1) peer- schistosomiasis will reduce morbidity and decrease trans- reviewed studies of T. solium taeniosis/cysticercosis in mission, which might also carry the added benefit of con- Africa, 2) “grey literature” on T. solium taeniosis/cysticer- trolling other infections in co-endemic areas such as cosis presence in Africa which consisted of informally pub- T. solium taeniosis/cysticercosis [7]. A way forward for lished written materials such as reports and theses, 3) control of T. solium is integration with schistosomiasis official reports of national pig populations in Africa avail- control programmes. However, the potential benefit of an able through national census data and FAOSTAT [16], integrated control effort against the two parasites has yet the statistical database of the Food and Agriculture to be evaluated. The anthelminthic drug used against Organization of the United Nations, 4) porcine cysticerco- schistosomiasis is praziquantel (PZQ) because of its safety sis reports from the World Organisation for Animal Health profile, easy administration, and mild side-effects [7]. The (OIE), and 5) the schistosomiasis prevalence map currently current recommended dose of PZQ for treatment of used by the WHO for assessing MDA intervals [17]. schistosomiasis is 40 mg/kg as a single dose [8]. PZQ has WeperformedaliteraturesearchusingPubMed(http:// proved highly efficacious against taeniosis at a dose of 5– www.ncbi.nlm.nih.gov/pubmed/) with date restriction from 10 mg/kg [9], and the drug can therefore be used against 01-01-1985 to 05-01-2015 using the following search term: both parasites. However, the dose recommended for schis- (solium OR Tapeworm OR Taeniasis OR Taeni* OR Tae- tosomiasis treatment may increase the risk of seizures in niosis OR Neurocysticercosis OR Cysticerc* OR cellulosae) people who are suffering from human cysticercosis where AND (Algeria OR Angola OR Benin OR Botswana OR the larvae are lodged in the central nervous system (neu- Burkina Faso OR Burundi OR Cameroon OR Central rocysticercosis, NCC). Even a single dose, lower than that African Republic OR Chad OR Congo OR Zaire OR recommended for schistosomiasis treatment, has been re- Cote d’Ivoire OR Ivory Coast OR Djibouti OR Egypt OR ported to induce seizures [10]. Flisser and colleagues [11] Equatorial Guinea OR Eritrea OR Ethiopia OR Gabon reported suspected cases of NCC based on clinical signs OR Gambia OR Ghana OR Guinea OR Guinea-Bissau following treatment with 5 mg/kg PZQ, and in a follow- OR Kenya OR Lesotho OR Liberia OR Libya OR up of 2452 participants subjected to an MDA using PZQ Madagascar OR Malawi OR Mali OR Mauritania OR at 5 mg/kg where of 1.3 % reported complaints of severe Morocco OR Mozambique OR Namibia OR Niger headache after treatment. Although MDA has been widely OR Nigeria OR Rwanda OR Senegal OR Sierra Leone applied for control of schistosomiasis in Africa, the safety OR Somalia OR South Africa OR South Sudan OR of PZQ in MDA in communities where schistosomiasis Sudan OR Swaziland OR Tanzania OR Togo OR Tunisia and NCC coexist is yet to be systematically assessed. OR Uganda OR Zambia OR Zimbabwe). We also searched The distribution of T. solium taeniosis/cysticercosis in other databases such as Google Scholar (http://scholar. Africa is unclear and up-to-date prevalence maps do not google.com), Thomson Reuter’s Web of Knowledge exist. The distribution of schistosomiasis is also to some (http://www.wokinfo.com), Cab Direct (http://www.cab extent uncertain, but through the work of the Global direct.org), Société de Pathologie Exotique (http://www. Neglected Tropical Diseases Database (GNTD; http:// pathexo.fr/), ProMED (http://www.isid.org), and African www.gntd.org), a prevalence map based on more than Journals Online (http://www.ajol.info) using the following 20,000 locations can be created. The database is con- keywords: “Taenia solium”, “porcine cysticercosis”, “Cysti- tinuously updated with the goal to use the information cercus cellulosae”, “neurocysticercosis”, “human cysticerco- for public health campaigns against schistosomiasis. sis”, “taeniosis”,and“taeniasis”. In addition, references With the launch of online virtual globes such as Google found in suitable articles were also investigated to compile Earth, online gazetteers have become a useful tool for all known studies on presence of T. solium and prevalence geo-referencing of locations and also disease distribu- of taeniosis and porcine cysticercosis. tion. The GNTD has used online gazetteers in order to geographically locate the distribution of schistosomia- Data extraction sis [12], which in turn have been utilised for modelling

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    14 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us